Synergistic activity and mechanism of action of Stephania suberosa Forman extract and ampicillin combination against ampicillin-resistant Staphylococcus aureus

Article English OPEN
Teethaisong, Yothin; Autarkool, Nongluk; Sirichaiwetchakoon, Kittipot; Krubphachaya, Pongrit; Kupittayanant, Sajeera; Eumkeb, Griangsak;
  • Publisher: Springer Nature
  • Journal: Journal of Biomedical Science,volume 21,issue 1 (issn: 1423-0127, eissn: 1423-0127)
  • Publisher copyright policies & self-archiving
  • Related identifiers: pmc: PMC4428530, doi: 10.1186/s12929-014-0090-2
  • Subject: β-lactam antibiotics | Molecular Biology | Biochemistry, medical | Synergistic activity | Ampicillin-resistant S. aureus (ARSA) Stephania suberosa Forman | Ampicillin | Cell Biology | Endocrinology, Diabetes and Metabolism | Clinical Biochemistry | Research | Pharmacology (medical)

Background Ampicillin-resistant S. aureus (ARSA) now poses a serious problem for hospitalized patients, and their care providers. Plant-derived antibacterial that can reverse the resistance to well-tried agents which have lost their original effectiveness are the resear... View more
  • References (51)
    51 references, page 1 of 6

    1. Huttner A, Harbarth S, Carlet J, Cosgrove S, Goossens H, Holmes A, Jarlier V, Voss A, Pittet D: Antimicrobial resistance: a global view from the 2013 World Healthcare-Associated Infections Forum. Antimicrob Resist Infect Control 2013, 2:31.

    2. Chambers HF: The changing epidemiology of Staphylococcus aureus? Emerg Infect Dis 2001, 7:178-182.

    3. Karlsson-Kanth A, Tegmark-Wisell K, Arvidson S, Oscarsson J: Natural human isolates of Staphylococcus aureus selected for high production of proteases and alpha-hemolysin are sigmaB deficient. Int J Med Microbiol 2006, 296:229-236.

    4. Mun SH, Joung DK, Kim YS, Kang OH, Kim SB, Seo YS, Kim YC, Lee DS, Shin DW, Kweon KT, Kwon DY: Synergistic antibacterial effect of curcumin against methicillin-resistant Staphylococcus aureus. Phytomedicine 2013, 20:714-718.

    5. Engemann JJ, Carmeli Y, Cosgrove SE, Fowler VG, Bronstein MZ, Trivette SL, Briggs JP, Sexton DJ, Kaye KS: Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis 2003, 36:592-598.

    6. Laupland KB, Lyytikainen O, Sogaard M, Kennedy KJ, Knudsen JD, Ostergaard C, Galbraith JC, Valiquette L, Jacobsson G, Collignon P, Schonheyder HC: The changing epidemiology of Staphylococcus aureus bloodstream infection: a multinational population-based surveillance study. Clin Microbiol Infect 2013, 19:465-471.

    7. Mehta S, Singh C, Plata KB, Chanda PK, Paul A, Riosa S, Rosato RR, Rosato AE: beta-Lactams increase the antibacterial activity of daptomycin against clinical methicillin-resistant Staphylococcus aureus strains and prevent selection of daptomycin-resistant derivatives. Antimicrob Agents Chemother 2012, 56:6192-6200.

    8. Jimenez JN, Ocampo AM, Vanegas JM, Rodriguez EA, Mediavilla JR, Chen L, Muskus CE, Velez LA, Rojas C, Restrepo AV, Garces C, Kreiswirth BN, Correa MM: A comparison of methicillin-resistant and methicillin-susceptible Staphylococcus aureus reveals no clinical and epidemiological but molecular differences. Int J Med Microbiol 2013, 303:76-83.

    9. Eumkeb G, Sakdarat S, Siriwong S: Reversing beta-lactam antibiotic resistance of Staphylococcus aureus with galangin from Alpinia officinarum Hance and synergism with ceftazidime. Phytomedicine 2010, 18:40-45.

    10. Arede P, Milheirico C, de Lencastre H, Oliveira DC: The anti-repressor MecR2 promotes the proteolysis of the mecA repressor and enables optimal expression of beta-lactam resistance in MRSA. PLoS Pathog 2012, 8:e1002816.

  • Related Research Results (1)
  • Related Organizations (2)
  • Metrics
Share - Bookmark